<DOC>
	<DOCNO>NCT02934334</DOCNO>
	<brief_summary>The Wellness Monitoring Major Depressive Disorder ( MDD ) study prospective , longitudinal , observational study aim identify biomarkers relapse MDD . Results may help refine clinical approach relapse management , may ultimately help MDD patient sustain wellness antidepressant medication .</brief_summary>
	<brief_title>Wellness Monitoring Major Depressive Disorder</brief_title>
	<detailed_description>This involve naturalistic follow responder study entitle `` Integrated biological marker prediction treatment response depression '' , CAN-BIND-1 study . Since patient usually seek medical attention relapse occur , imminent precursor relapse well know . This study , participant currently respond oral antidepressant treatment regimen monitor one-year period , provide unique opportunity discover near-term biomarkers relapse .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Meet DSMV criterion Major Depressive Episode ( MDE ) MDD determine MINI . MADRS total score equal less 14 . In current MDE , patient must currently respond antidepressant medication . Willing able complete selfreported assessment via studyspecific smartphone ( LogPad ) , include sufficient fluency English . Willing wear GT9X Link , wristworn device duration study . Axis I diagnosis , MDD , consider primary diagnosis . Bipolar I Bipolar II diagnosis ( lifetime ) , MDD psychotic feature ( lifetime ) , schizophrenia , schizoaffective disorder . Presence significant Axis II diagnosis ( borderline , antisocial ) . High suicidal risk , define clinician judgement . History drug alcohol use , severity least moderate severe , accord DSM criterion , within 6 month screen . Presence significant neurological disorder , head trauma , unstable medical condition . Received investigational drug ( include investigational vaccine ) use invasive investigational medical device within 90 day screen currently enrol investigational study . Has condition , opinion investigator , participation would best interest subject ( e.g . compromise well ) could prevent , limit , confound protocolspecified assessment . Subject employee investigator study site , direct involvement propose study study direction investigator study site , family member employee investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>major depression</keyword>
	<keyword>major depressive episode</keyword>
	<keyword>biomarkers</keyword>
	<keyword>relapse</keyword>
	<keyword>near term relapse</keyword>
	<keyword>m-health</keyword>
</DOC>